RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Clinical trials for RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Lower-Dose combo aims to tame tough lymphoma, pave way for transplant
Disease control Recruiting nowThis study is testing if a lower dose of the drug epcoritamab, when combined with standard chemotherapy drugs, can help control aggressive lymphoma that has returned or not responded to prior treatment. The goal is to shrink the cancer enough so patients can safely proceed with a…
Matched conditions: RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Hospital Universitario Dr. Jose E. Gonzalez • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New hope for lymphoma patients Who've run out of options
Disease control Recruiting nowThis study is testing whether adding a new drug called selinexor to standard chemotherapy works better for people with aggressive lymphoma that has returned or stopped responding to previous treatments. The trial will involve about 500 patients who cannot receive stem cell transp…
Matched conditions: RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA
Phase: PHASE2, PHASE3 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC